Patents by Inventor Richard W. Barnett

Richard W. Barnett has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Treatment of herpesvirus infection
    Patent number: 5831001
    Abstract: Described herein are oligopeptides useful to inhibit replication of herpesviruses, especially herpes simplex viruses. In a preferred embodiment of the invention, the oligopeptide is a D-arginine nonamer having N- and C-terminal protecting groups, which, at a 5 uM concentration, exhibits greater than 95% inhibition of HSV-1 replication, in a standard assay.
    Type: Grant
    Filed: January 26, 1995
    Date of Patent: November 3, 1998
    Assignee: Allelix Biopharmaceuticals Inc.
    Inventors: Michael Twist, Richard W. Barnett, Lorne S. Reid, Martin Sumner-Smith
  • Peptide-based inhibitors of HIV replication
    Patent number: 5789531
    Abstract: Described herein are oligopeptides useful to inhibit replication in virally infected individuals. In a preferred embodiment of the invention, the oligopeptide is a D-arginine nonamer having N- and C-terminal protecting groups, which, at a 3 uM concentration, exhibits greater than 95% inhibition of HIV replication, in a standard assay.
    Type: Grant
    Filed: June 7, 1995
    Date of Patent: August 4, 1998
    Assignee: Allex Biopharmaceuticals, Inc.
    Inventors: Martin Sumner-Smith, Richard W. Barnett, Lorne S. Reid, Nahum Sonenberg
  • Peptide-based inhibitors of HIV replication
    Patent number: 5646120
    Abstract: Described herein are oligopeptides useful to inhibit replication in virally infected individuals. In a preferred embodiment of the invention, the oligopeptide is a D-arginine nonamer having N- and C-terminal protecting groups, which, at a 5 uM concentration, exhibits greater than 95% inhibition of HIV replication, in a standard assay.
    Type: Grant
    Filed: December 14, 1994
    Date of Patent: July 8, 1997
    Assignee: Allelix Biopharmaceuticals, Inc.
    Inventors: Martin Sumner-Smith, Richard W. Barnett, Lorne S. Reid, Nahum Sonenberg